However, MLKL-G316D substitution, which fully ablates MLKL killing activity in human cells was observed exclusively in diabetic patients, suggesting a potential role of impairment of necroptosis pathway in promoting diabetes [140]. This evidence concerns the gene MLKL and diabetes mellitus.